Average Co-Inventor Count = 5.22
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ascendis Pharma Growth Disorders A/s (9 from 12 patents)
2. Ascendis Pharma Bone Diseases A/s (8 from 10 patents)
3. Sanofi-A Ventis Deutschland Gmbh (4 from 1,832 patents)
4. Ascendis Pharma A/s (2 from 45 patents)
23 patents:
1. 12453778 - Incremental dose finding in controlled-release PTH compounds
2. 12403182 - Liquid pharmaceutical formulations of PTH conjugates
3. 12239689 - Controlled-release CNP agonists with low initial NPR-B activity
4. 12214020 - PTH prodrugs
5. 12156917 - CNP prodrugs with carrier attachment at the ring moiety
6. 12083182 - Controlled-release CNP agonists with increased NEP stability
7. 11918628 - Controlled-release PTH compound
8. 11890326 - Controlled-release PTH compound
9. 11857603 - PTH compounds with low peak-to-trough ratios
10. 11793861 - PTH prodrugs
11. 11759504 - PTH compounds with low peak-to-trough ratios
12. 11633487 - Prodrugs comprising an aminoalkyl glycine linker
13. 11413351 - CNP prodrugs with carrier attachment at the ring moiety
14. 11389510 - Controlled-release CNP agonists with low initial NPR-B activity
15. 11389511 - Controlled-release CNP agonists with reduced side-effects